🇺🇸 FDA
Patent

US 10280158

Immune adjustment compound, use thereof and pharmaceutical composition comprising same

granted A61PA61P1/00A61P1/04

Quick answer

US patent 10280158 (Immune adjustment compound, use thereof and pharmaceutical composition comprising same) held by SuZhou Connect Biopharmaceuticals, Inc. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SuZhou Connect Biopharmaceuticals, Inc.
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/06, A61P17/06